Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury framingham study

Stroke

Volumn 44, Issue 10, 2013, Pages 2768-2775

  Pikula, Aleksandra ^a,b   Beiser, Alexa S ^a,b   Chen, Tai C ^a   Preis, Sarah R ^a,b   Vorgias, Demetrios ^a   Decarli, Charles ^b,c   Au, Rhoda ^a,b   Kelly Hayes, Margaret ^a,b   Kase, Carlos S ^a,b   Wolf, Philip A ^a,b   Vasan, Ramachandran S ^a,b   Seshadri, Sudha ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FRAMINGHAM HEART STUDY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain mri; Brain derived neurotrophic factor; Risk; Stroke; Subclinical; Vascular endothelial growth factor a

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN DERIVED NEUROTROPHIC FACTOR BLOOD LEVEL; BRAIN INJURY; BRAIN SIZE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COGNITION; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; SPATIAL MEMORY; TRANSIENT ISCHEMIC ATTACK; VASCULOTROPIN BLOOD LEVEL; VISUAL MEMORY; WHITE MATTER;

BRAIN MRI; BRAIN-DERIVED NEUROTROPHIC FACTOR; RISK; STROKE; SUBCLINICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

AGE FACTORS; AGED; BRAIN ISCHEMIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; STROKE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888359140     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001447     Document Type: Article

References (45)

1. Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, et al. Dementia after stroke: The Framingham Study. Stroke. 2004, 35:1264-1268.
2. Gresham GE, Kelly-Hayes M, Wolf PA, Beiser AS, Kase CS, D'Agostino RB. Survival and functional status 20 or more years after first stroke: The Framingham Study. Stroke. 1998, 29:793-797.
3. Christensen H, Anstey KJ, Parslow RA, Maller J, Mackinnon A, Sachdev P. The brain reserve hypothesis, brain atrophy and aging. Gerontology. 2007, 53:82-95.
4. Cramer SC. Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery. Ann Neurol. 2008, 63:272-287.
5. Emanueli C, Schratzberger P, Kirchmair R, Madeddu P. Paracrine control of vascularization and neurogenesis by neurotrophins. Br J Pharmacol. 2003, 140:614-619.
6. Pucci S, Mazzarelli P, Missiroli F, Regine F, Ricci F. Neuroprotection: VEGF, IL-6, and clusterin: The dark side of the moon. Prog Brain Res. 2008, 173:555-573.
7. Golden E, Emiliano A, Maudsley S, Windham BG, Carlson OD, Egan JM, et al. Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging. PLoS One. 2010, 5:e10099.
8. Ferris LT, Williams JS, Shen CL. The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function. Med Sci Sports Exerc. 2007, 39:728-734.
9. Blann AD, Belgore FM, McCollum CN, Silverman S, Lip PL, Lip GY. Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes. Clin Sci (Lond). 2002, 102:187-194.
10. Lieb W, Safa R, Benjamin EJ, Xanthakis V, Yin X, Sullivan LM, et al. Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function. Eur Heart J. 2009, 30:1121-1127.
11. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: A risk profile from the Framingham Study. Stroke. 1991, 22:312-318.
12. Lennmyr F, Ata KA, Funa K, Olsson Y, Terént A. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol. 1998, 57:874-882.
13. Santhanam AV, Smith LA, Katusic ZS. Brain-derived neurotrophic factor stimulates production of prostacyclin in cerebral arteries. Stroke. 2010, 41:350-356.
14. Au R, Massaro JM, Wolf PA, Young ME, Beiser A, Seshadri S, et al. Association of white matter hyperintensity volume with decreased cognitive functioning: The Framingham Heart Study. Arch Neurol. 2006, 63:246-250.
15. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: The Framingham Study. Am J Public Health Nations Health. 1951, 41:279-281.
16. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol. 1979, 110:281-290.
17. De Carli C, Massaro J, Harvey D, Hald J, Tullberg M, Au R, et al. Measures of brain morphology and infarction in the Framingham heart study: establishing what is normal. Neurobiol Aging. 2005, 26:491-510.
18. Farmer ME, White LR, Kittner SJ, Kaplan E, Moes E, McNamara P, et al. Neuropsychological test performance in Framingham: A descriptive study. Psychol Rep. 1987, 60(3 pt 2):1023-1040.
19. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke- Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006, 37:2220-2241.
20. Beekman AT, Deeg DJ, Van Limbeek J, Braam AW, De Vries MZ, Van Tilburg W. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychol Med. 1997, 27:231-235.
21. Kannel WB, Sorlie P. Some health benefits of physical activity. The Framingham Study. Arch Intern Med. 1979, 139:857-861.
22. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011, 30:11-21.
23. Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke. 2000, 31:1863-1870.
24. Lee SC, Lee KY, Kim YJ, Kim SH, Koh SH, Lee YJ. Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis. Eur J Neurol. 2010, 17:45-51.
25. Kleim JA, Jones TA, Schallert T. Motor enrichment and the induction of plasticity before or after brain injury. Neurochem Res. 2003, 28:1757-1769.
26. Schäbitz WR, Steigleder T, Cooper-Kuhn CM, Schwab S, Sommer C, Schneider A, et al. Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke. 2007, 38:2165-2172.
27. Tsukahara T, Yonekawa Y, Tanaka K, Ohara O, Wantanabe S, Kimura T, et al. The role of brain-derived neurotrophic factor in transient forebrain ischemia in the rat brain. Neurosurgery. 1994, 34:323-331.
28. Zachary I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals. 2005, 14:207-221.
29. Sandhofer A, Tatarczyk T, Kirchmair R, Iglseder B, Paulweber B, Patsch JR, et al. Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study. Atherosclerosis. 2009, 206:265-269.
30. Guo S, Kim WJ, Lok J, Lee SR, Besancon E, Luo BH, et al. Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. Proc Natl Acad Sci U S A. 2008, 105: 7582-7587.
31. Han J, Pollak J, Yang T, Siddiqui MR, Doyle KP, Taravosh-Lahn K, et al. Delayed administration of a small molecule tropomyosin-related kinase B ligand promotes recovery after hypoxic-ischemic stroke. Stroke. 2012, 43:1918-1924.
32. Issa R, Krupinski J, Bujny T, Kumar S, Kaluza J, Kumar P. Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab Invest. 1999, 79:417-425.
33. Khurana R, Simons M, Martin JF, Zachary IC. Role of angiogenesis in cardiovascular disease: A critical appraisal. Circulation. 2005, 112:1813-1824.
34. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010, 341:c3666.
35. Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, et al. Stroke risk profile predicts white matter hyperintensity volume: The Framingham Study. Stroke. 2004, 35:1857-1861.
36. Debette S, Beiser A, DeCarli C, Au R, Himali JJ, Kelly-Hayes M, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: The Framingham Offspring Study. Stroke. 2010, 41:600-606.
37. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J, et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost. 2002, 87:728-734.
38. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, et al. BDNF genotype potentially modifying the association between incident stroke and depression. Neurobiol Aging. 2008, 29:789-792.
39. Sato Y, Chin Y, Kato T, Tanaka Y, Tozuka Y, Mase M, et al. White matter activated glial cells produce BDNF in a stroke model of monkeys. Neurosci Res. 2009, 65:71-78.
40. Waterhouse EG, Xu B. New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci. 2009, 42: 81-89.
41. Durany N, Michel T, Kurt J, Cruz-Sánchez FF, Cervás-Navarro J, Riederer P. Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains. Int J Dev Neurosci. 2000, 18:807-813.
42. Peng S, Wuu J, Mufson EJ, Fahnestock M. Precursor form of brainderived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem. 2005, 93:1412-1421.
43. Gunstad J, Benitez A, Smith J, Glickman E, Spitznagel MB, Alexander T, et al. Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults. J Geriatr Psychiatry Neurol. 2008, 21:166-170.
44. Komulainen P, Pedersen M, Hänninen T, Bruunsgaard H, Lakka TA, Kivipelto M, et al. BDNF is a novel marker of cognitive function in ageing women: The DR's EXTRA Study. Neurobiol Learn Mem. 2008, 90:596-603.
45. Seshadri S, Wolf PA, Beiser A, Elias MF, Au R, Kase CS, et al. Stroke risk profile, brain volume, and cognitive function: The Framingham Offspring Study. Neurology. 2004, 63:1591-1599.